LAMTOR5 and breast carcinoma: Although the reasons of breast cancer promotion by HBV remain obscure and lack high-quality of epidemiological data, many researches in vitro have studied the function of HBX and hepatitis B X-interacting protein (HBXIP) on breast cancer cells [22–30].